Incline-Village Local Business

Local business in Incline-Village, NV

  • Monday Dec 15 | via Freshnews 

    PDL BioPharma Completes Regular Quarterly Dividend P...

    PDL BioPharma, Inc. today announced that it has paid the December 12, 2014, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of December 5, 2014, the record date. About PDL BioPharma PDL manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

    Comment?

    Related Topix: PDL BioPharma, Startups, Incline-Village, NV

  • Friday Dec 12 | via The Las Vegas Sun 

    Photo: In this photo provided by Scott Sady of Tahoe...

    In this photo provided by Scott Sady of TahoeLight.com, Jessica Yurtinis of Reno, Nev., paddles her kayak through the five- to seven-foot waves on Lake Tahoe kicked up by a strong storm moving across California and Nevada, near Incline Village, Nev., Thursday, Dec 11, 2014. Winds gusting to 140 mph whipped through Sierra Nevada mountain passes ahead of a powerful wet Pacific storm Thursday, toppling trees and damaging homes in the Lake Tahoe area and grounding commercial airline flights in Reno, authorities said.

    Comment?

    Related Topix: Reno, NV, Incline-Village, NV, Weather, Manufacturing, Sierra Nevada, Aerospace-Defense

  • Wednesday Dec 10 | via Freshnews 

    PDL BioPharma Provides Fourth Quarter 2014 Revenue G...

    PDL BioPharma, Inc. today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately $158 million, as compared with actual revenue of $112 million for the fourth quarter of 2013, an approximate 41 percent increase. The forecasted revenues for the fourth quarter of 2014 include royalty payments from PDL's licensees to the Queen et al. patents, the estimated change in fair value of the acquired royalty rights, and estimated interest revenue from notes receivable debt financings to late stage healthcare companies.

    Comment?

    Related Topix: Startups, PDL BioPharma

  • Thursday Dec 4 | via Freshnews 

    PDL BioPharma Announces Conversion Rate Adjustments ...

    INCLINE VILLAGE, Nev., Dec. 4, 2014 /PRNewswire/ -- PDL BioPharma, Inc. today announced that the adjusted conversion rate for the: -- 3.75% Convertible Senior Notes due May 1, 2015 , is 171.1768 shares of common stock per $1,000 principal amount or approximately $5.84 per share, effective December 3, 2014? and -- 2.875% Series 2012 Convertible Senior Notes due February 15, 2015 , is 195.248 shares of common stock per $1,000 principal amount or approximately $5.12 per share, effective December 3, 2014. The conversion rates for the notes are adjusted in connection with the regular quarterly dividend of $0.15 to be paid on December 12, 2014, to all stockholders who own shares of PDL on December 5, 2014, the record date.

    Comment?

    Related Topix: Startups, PDL BioPharma, Incline-Village, NV